OnKure Therapeutics, Inc. (OKUR)
Last updated: 2026-10-21 22:40:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
OnKure Therapeutics, Inc. (OKUR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.30, with a market capitalization of $91.12M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.01 to $5.38. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$91.12M | |
$2.37 | |
$20.00 | |
$1.70 | |
$2.36 | |
216.49K | |
248.54K | |
-- | |
$5.38 | |
$2.01 | |
-- | |
-- |
OnKure Therapeutics, Inc. (OKUR) After-Hours Stock Price
OnKure Therapeutics, Inc. (OKUR) is trading at $2.26 in after-hours trading as of 2026-10-21 19:59:56, down 4.24% ($0.10) from the regular-session close of $2.36.
After-hours trading shows how investors are pricing OKUR after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
OnKure Therapeutics, Inc. (OKUR) 7-Day Stock Price Change
Over the past seven days, OnKure Therapeutics, Inc. (OKUR) moved from $2.42 to $2.30, representing a decline of 5.17% ($0.13).
The stock traded between $2.01 and $2.48 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 318.96 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
OKUR 52-Week Price Position
Position in Range: 8.5%
OKUR is currently trading at $2.30, placing it 8.5% of the way from its 52-week low of $2.01 to its 52-week high of $5.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is OnKure Therapeutics, Inc. (OKUR)?
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
OnKure Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 45 |
| Exchange | NASDAQ |
| Company Website |
How to Buy OnKure Therapeutics, Inc. (OKUR) Stock on MEXC
Eligible investors can buy real shares of OnKure Therapeutics, Inc. (OKUR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is OnKure Therapeutics, Inc. (OKUR) stock price today?
2.Is OKUR stock going up or down today?
3.What is OKUR pre-market price?
4.What is OKUR after-hours price?
5.Is OKUR stock trading now?
6.Where does OKUR sit relative to its 52-week high and low?
7.What sector is OnKure Therapeutics, Inc. in?
8.What is OnKure Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is OKUR valued in terms of P/E ratio and EPS?
10.Does OnKure Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
OKUR Stock Calculator
Estimate the value between OKUR shares and USD.
OKUR Shares to USD
1.00 OKUR shares = 2.295 USD
Calculations are estimates based on the latest available price and are for reference only.


